Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
107.56
(
-0.64%
)
Bitcoin
67,603.92
(
2.50%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: DewDiligence post# 58596

Monday, 02/04/2008 6:42:07 PM

Monday, February 04, 2008 6:42:07 PM

Post# of 257302
TEVA/Amphastar: Wouldn't any anti-trust case infer that monetary damages are due despite no approved generic product? Or, perhaps, that the FDA was complicit by not approving a generic based on the existing patent, thus "constructively" blocking sales?
Seems like a long stretch, or is there precedent?

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today